$435.52
1.14% today
NYSE, Nov 07, 04:45 pm CET

Chemed Corporation Stock price

$430.59
-4.79 1.10% 1M
-145.92 25.31% 6M
-99.21 18.73% YTD
-119.40 21.71% 1Y
-53.65 11.08% 3Y
-64.19 12.97% 5Y
+272.09 171.67% 10Y
+382.59 797.06% 20Y
NYSE, Closing price Thu, Nov 06 2025
-8.41 1.92%

New AI Insights on Chemed Corporation Insights AI Insights on Chemed Corporation

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$6.1b
Enterprise Value
$6.0b
Net debt
-
Cash
$129.8m
Shares outstanding
14.6m
Valuation (TTM | estimate)
P/E
22.3 | 19.2
P/S
2.4 | 2.4
EV/Sales
2.4 | 2.3
EV/FCF
16.6
P/B
5.7
Dividends
DPS
$1.80
Yield 1Y | 5Y
0.4% | 0.3%
Growth 1Y | 5Y
15.4% | 7.7%
Payout 1Y | 3Y
9.1% | 8.9%
Increased
16 Years
Financials (TTM | estimate)
Revenue
$2.5b | $2.6b
EBITDA
$433.8m | $479.0m
EBIT
$369.4m | $404.0m
Net Income
$278.8m | $326.2m
Free Cash Flow
$360.4m
Growth (TTM | estimate)
Revenue
6.5% | 5.9%
EBITDA
-6.5% | 1.8%
EBIT
-7.9% | -0.8%
Net Income
-7.6% | 8.0%
Free Cash Flow
15.3%
Margin (TTM | estimate)
Gross
32.9%
EBITDA
17.1% | 18.6%
EBIT
14.6%
Net
11.0% | 12.7%
Free Cash Flow
14.2%
Financial Health
Equity Ratio
67.1%
Return on Equity
27.0%
ROCE
27.8%
ROIC
20.0%
Debt/Equity
-
More
EPS
$19.3
FCF per Share
$24.7
Short interest
4.9%
Employees
16k
Rev per Employee
$150.0k
Show more

Is Chemed Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Chemed Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Chemed Corporation forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Chemed Corporation forecast:

Buy
88%
Hold
13%

Financial data from Chemed Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,531 2,531
6% 6%
100%
- Direct Costs 1,699 1,699
11% 11%
67%
832 832
2% 2%
33%
- Selling and Administrative Expenses 398 398
4% 4%
16%
- Research and Development Expense - -
-
-
434 434
7% 7%
17%
- Depreciation and Amortization 64 64
3% 3%
3%
EBIT (Operating Income) EBIT 369 369
8% 8%
15%
Net Profit 279 279
8% 8%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Chemed Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Chemed Corporation Stock News

Neutral
GlobeNewsWire
3 days ago
CINCINNATI, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at approximately 2:00 p.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida.
Neutral
The Motley Fool
5 days ago
Schwartz Investment Counsel sold 28,771 shares of Chemed Corporation; estimated transaction value of approximately $13.03 million based on average third-quarter 2025 pricing Trade represented 0.4% of Schwartz's reportable U.S. equity assets under management as of Q3 2025 Post-trade stake: 111,033 shares valued at $49.71 million as of Q3 2025 Chemed now accounts for 1.67% of AUM as of September ...
Negative
The Motley Fool
8 days ago
EULAV Asset Management sold 28,313 shares of Chemed, estimated at ~$12.82 million. The transaction value represents 0.3% of EULAV Asset Management's 13F reportable assets under management (AUM) as of Q3 2025.
More Chemed Corporation News

Company Profile

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the following segments: VITAS and Roto-Rooter. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Head office United States
CEO Kevin McNamara
Employees 15,695
Founded 1970
Website www.chemed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today